S 16276

Drug Profile

S 16276

Alternative Names: S 162761

Latest Information Update: 22 Apr 1996

Price : $50

At a glance

  • Originator Servier
  • Class Antirheumatics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatic disorders

Most Recent Events

  • 22 Apr 1996 Discontinued-Preclinical for Rheumatic disorders (Unknown route)
  • 31 May 1995 A new in vivo study has been added to the pharmacodynamics section .
  • 31 May 1995 The new ATC/EphMRA codes for S 16276 are M01A-E/M1.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top